• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Day One Biopharmaceuticals, Inc. - Common Stock (NQ:DAWN)

    10.69 +0.19 (+1.76%)
    Streaming Delayed Price Updated: 10:42 AM EST, Jan 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 307,497
    Open 10.56
    Bid (Size) 10.68 (200)
    Ask (Size) 10.69 (300)
    Prev. Close 10.50
    Today's Range 10.50 - 10.83
    52wk Range 5.635 - 13.53
    Shares Outstanding 73,572,633
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Keep an eye on the top gainers and losers in Monday's session. ↗
    Via Chartmill
    Gapping stocks in Monday's session ↗
    Via Chartmill

    Performance

    YTD
    +20.7%
    +20.7%
    1 Month
    +29.5%
    +29.5%
    3 Month
    +43.0%
    +43.0%
    6 Month
    +64.4%
    +64.4%
    1 Year
    -10.0%
    -10.0%

    More News

    Read More
    Top movers in Monday's pre-market session ↗
    Via Chartmill
    News headline image
    Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    Curious about the stocks that are showing activity after the closing bell on Friday? ↗
    Via Chartmill
    News headline image
    Day One Completes Acquisition of Mersana Therapeutics
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Mersana Therapeutics Stock Explodes Over 200% To Notch Best Day Ever As $285M Buyout Trumps Analyst Downgrades: Retail Cheers ‘Very Good Bargain’ ↗
    Via Stocktwits
    News headline image
    Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout ↗
    Via Benzinga
    News headline image
    Mersana Catapults 200% On Day One Bio's Surprise Buyout ↗
    Via Investor's Business Daily
    News headline image
    MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal ↗
    Via Stocktwits
    News headline image
    Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Day One (DAWN) Q2 Revenue Jumps 313% ↗
    Via The Motley Fool
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Day One Biopharmaceuticals Inc (NASDAQ:DAWN) Reports Q2 2025 Earnings: Revenue Growth but Wider-Than-Expected Loss ↗
    Via Chartmill

    Frequently Asked Questions

    Is Day One Biopharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Day One Biopharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Day One Biopharmaceuticals, Inc. - Common Stock trade on?
    Day One Biopharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock is DAWN on the Nasdaq Stock Market
    What is the current price of Day One Biopharmaceuticals, Inc. - Common Stock?
    The current price of Day One Biopharmaceuticals, Inc. - Common Stock is 10.69
    When was Day One Biopharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Day One Biopharmaceuticals, Inc. - Common Stock was at 01/16/26 10:42 AM ET
    What is the market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock?
    The market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock is 786.12M
    How many shares of Day One Biopharmaceuticals, Inc. - Common Stock are outstanding?
    Day One Biopharmaceuticals, Inc. - Common Stock has 786M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.